DXCM · DexCom, Inc.

S&P 500 #150 · NASDAQ-100 #99 · Nasdaq

Risiko 6/10 · elevated · $74.85 ▲ 2.02%

Kennzahlen

• Price $74.85
• Market cap $28.9B
• P/E (ttm) 32.12
• Div yield none
• 52-wk range $54.11 – $89.98
• Index rank #150 / #99

Wichtigste Risiken

• CGM price competition (Abbott Libre) — HIGH
• GLP-1 demand impact (weight-loss drugs) — MED
• Reimbursement pressure (payers) — MED
• Margin compression (hardware costs) — LOW

Fazit

Continuous-glucose-monitor leader squeezed by Abbott competition and GLP-1 uncertainty around diabetes volumes.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.